バイエルのインスタグラム(bayerofficial) - 4月16日 00時30分

Effective Hemophilia Treatment - Providing blood Factor VIII
Hemophilia is a rare bleeding disorder where one of the clotting factors is missing or deficient that affects your blood’s ability to clot normally.
The most common type of hemophilia is Hemophilia A. It is caused by a missing protein called factor VIII. This is a protein in the coagulation cascade – a series of reactions that occur in your blood and signal when it should clot.
Bayer has played a major role in the development of treatments for hemophilia A, a lifelong bleeding disorder that prevents blood from clotting properly. People with hemophilia do not have enough clotting Factor VIII, a special blood protein. Injected regularly, blood coagulation Factor VIII replaces the endogenous proteins that the affected patients lack. Its production of requires ultrapure water.
On the picture you see a Bayer employee at a production site in Berkeley, United States.

#science #education #meds #medic #medical #doctor #lifescience #betterlife # #chemistry #biology #scientist
#agameoftones #artofvisuals #makemoments #makeportraits #visualsoflife #shoot2kill #way2ill #justgoshoot #liveauthentic #thecreatorclass #peoplescreatives #letsgosomewhere #everydayeverywhere #illgrammers #createexplorey #chasinglight

[BIHAKUEN]UVシールド(UVShield)

>> 飲む日焼け止め！「UVシールド」を購入する